Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study's Indiana-based affiliation was updated from Indiana University School of Medicine to Indiana University, changing the credited institution in the collaborators/locations section. This reflects a broader institutional naming for the site and may affect how the record is identified in communications and databases.
    Difference
    0.2%
    Check dated 2026-05-08T03:23:58.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s revision/build indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.5.0 to Revision: v3.5.2. This indicates a minor site maintenance update with no changes to study content or data visible on the page.
    Difference
    0.1%
    Check dated 2026-04-16T12:37:47.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:48.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:05:23.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the previous funding/operating-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:16:08.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.